Show simple item record

Racial differences in colorectal cancer survival in the Detroit Metropolitan area

dc.contributor.authorYan, Benen_US
dc.contributor.authorNoone, Anne-Michelleen_US
dc.contributor.authorYee, Cecilia L.en_US
dc.contributor.authorBanerjee, Mousumien_US
dc.contributor.authorSchwartz, Kendra L.en_US
dc.contributor.authorSimon, Michael S.en_US
dc.date.accessioned2009-09-02T14:39:42Z
dc.date.available2010-10-05T18:27:30Zen_US
dc.date.issued2009-08-15en_US
dc.identifier.citationYan, Ben; Noone, Anne-Michelle; Yee, Cecilia; Banerjee, Mousumi; Schwartz, Kendra; Simon, Michael S. (2009). "Racial differences in colorectal cancer survival in the Detroit Metropolitan area." Cancer 115(16): 3791-3800. <http://hdl.handle.net/2027.42/63614>en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.issn1097-0142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/63614
dc.description.abstractBACKGROUND: Colorectal carcinoma is the second most common cause of cancer death with African Americans having lower survival compared with White Americans. The purpose of this study was to investigate the effect of demographics, clinical factors, and socioeconomic status (SES) on racial disparities in colorectal cancer survival in the Detroit Metropolitan Area. METHODS: The study population included 9078 individuals with primary invasive colorectal cancer identified between 1988 and 1992 through the Surveillance, Epidemiology, and End Results (SEER) program. Demographics, clinical information, and survival were obtained through SEER. SES was categorized using occupation, educational level, and poverty status at the census tract level. Kaplan-Meier survival curves and Cox proportional hazards regression were used to compare overall survival by race. RESULTS: African Americans were more likely to be diagnosed with stage IV disease ( P < .001), and to reside within poor census tracts ( P < .001) compared with White Americans. Unadjusted analysis showed that African Americans had a significantly higher risk of death compared with their White American counterparts (hazards ratio [HR], 1.13; 95% confidence interval [CI], 1.07-1.20). After adjusting for age, marital status, sex, SES group, TNM stage, and treatment, race was no longer significantly associated with overall survival (HR, 1.00; 95% CI, 0.92-1.09). Similar results were seen with colorectal cancer-specific survival. CONCLUSIONS: Racial disparities in colorectal cancer survival dissipate after adjusting for other demographic and clinical factors. These results can potentially affect medical guidelines regarding screening and treatment, and possibly influence public health policies that can have a positive impact on equalizing racial differences in access to care. Cancer 2009. © 2009 American Cancer Society.en_US
dc.format.extent150133 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherCancer Research, Oncology and Pathologyen_US
dc.titleRacial differences in colorectal cancer survival in the Detroit Metropolitan areaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Internal Medicine, Henry Ford Hospital and Medical Center, Detroit, Michiganen_US
dc.contributor.affiliationotherDepartment of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DCen_US
dc.contributor.affiliationotherPopulation Studies and Prevention Program, Karmanos Cancer Institute at Wayne State University, Detroit, Michiganen_US
dc.contributor.affiliationotherPopulation Studies and Prevention Program, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan ; Department of Family Medicine & Public Health Sciences, Wayne State University, Detroit, Michiganen_US
dc.contributor.affiliationotherPopulation Studies and Prevention Program, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan ; Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan ; Fax: (313) 576-8764 ; Barbara Ann Karmanos Cancer Institute, 4100 John R, Room 4221, Hudson Weber Cancer Research Center, Detroit, MI 48201en_US
dc.identifier.pmid19598220en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/63614/1/24408_ftp.pdf
dc.identifier.doi10.1002/cncr.24408en_US
dc.identifier.sourceCanceren_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.